Expression of pleiotrophin, an important regulator of cell migration, is inhibited in intestinal epithelial cells by treatment with non-steroidal anti-inflammatory drugs

Growth Factors

Volumn 30, Issue 4, 2012, Pages 258-266

  Silver, Kristopher ^a   Desormaux, Alejandra ^b   Freeman, Lisa C ^b   Lillich, James D ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

Cell migration; Epithelia; NSAID; Pleitrophin

Indexed keywords

INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PLEIOTROPHIN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; GASTROINTESTINAL TRACT; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; ULCEROGENESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE AND BONES; CARRIER PROTEINS; CELL LINE; CELL MOVEMENT; CYTOKINES; EPITHELIAL CELLS; HORSES; INDOMETHACIN; INTESTINES; NEOVASCULARIZATION, PATHOLOGIC; NITROBENZENES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENYLBUTAZONE; SULFONAMIDES; TISSUE DISTRIBUTION;

EQUIDAE;

EID: 84866140670     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2012.693920     Document Type: Article

References (46)

1. Ashton M Hanson PJ. 2002. Disparate effects of non-steroidal antiinflammatory drugs on apoptosis in guinea pig gastric mucous cells: Inhibition of basal apoptosis by diclofenac. Br J Pharmacol 135:407-416.
2. Cryer B. 2005. NSAID-associated deaths: The rise and fall of NSAID-associated GI mortality. Am J Gastroenterol 100: 1694-1695.
3. Delco F Michetti P Beglinger C Fried M Szucs TD. 2004. Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. Digestion 69:10-19.
4. Deuel TF Zhang N Yeh H-J Silos-Santiago I Wang Z-Y. 2002. Pleiotrophin: A cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397:162-171.
5. Dignass AU. 2001. Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 7:68-77.
6. Dineen SP Lynn KD Holloway SE Miller AF Sullivan JP Shames DS Beck AW Barnett CC Fleming JB Brekken RA. 2008. Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. Cancer Res 68:4340-4346.
7. Fendrick AM Greenberg BP. 2009. A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis. Osteopath Med Prim Care 3:1-7.
8. Freeman LC Narvaez DF McCoy A von Stein FB Young S Silver K Ganta S Koch D Hunter R Gilmour RF Lillich JD. 2007. Depolarization and decreased surface expression of K channels contribute to NSAID-inhibition of intestinal restitution. Biochem Pharmacol 74:74-85.
9. Frey HH El-Sayed MA. 1977. Concentrations of acidic antiinflammatory drugs in gastric mucosa. Arch Int Pharmacodyn Ther 230:300-308.
10. Glading A Chang P Lauffenburger DA Wells A. 2000. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem 275:2390-2398.
11. Glading A Uberall F Keyse S Lauffenburger DA Wells A. 2001. Membrane proximal ERK signaling is required for m-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem 276:23341-23348.
12. Glading A Bodnar RJ Reynolds IJ Shiraha H Satish L Potter DA Blair HC Wells A. 2004. Epidermal growth factor activates mcalpain (calpain II) at least in part by extracellular signalregulated kinase-mediated phosphorylation. Mol Cell Biol 24: 2499-2512.
13. Israel LH Koea JB Stewart ID Wright CL Frankish PD. 2001. Nonsteroidal anti-inflammatory drug-induced strictures of the colon. Dis Colon Rectum 44:1362-1364.
14. Karcher LF Dill SG Anderson WI King JM. 1990. Right dorsal colitis. J Vet Intern Med 4:247-253.
15. Kato M Nishida S Kitasato H Sakata N Kawai S. 2001. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of nonsteroidal anti-inflammatory drugs: Investigation using human peripheral monocytes. J Pharm Pharmacol 53:1679-1685.
16. Kokoska ER Smith GS Deshpande Y Wolff AB Miller TA. 1998. Indomethacin increases susceptibility to injury in human gastric cells independent of PG synthesis inhibition. Am J Physiol 275: G620-G628.
17. Lichtenberger LM. 2001. Where is the evidence that cyclooxygenase inhibition is the primary cause of neonsteroidal antiinflammatory drug (NSAID)-induced gastrointestinal injury?Topical injury revisited. Biochem Pharmacol 61:631-637.
18. MacAllister CG Morgan SJ Borne AT Pollet RA. 1993.Comparison of adverse effects of phenylbutazone flunixin meglumine and ketoprofen in horses. J Am VetMed Assoc 202: 71-77.
19. Mahmud T Rafi SS Scott DL Wrigglesworth JM Bjarnason I. 1996. Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. Arthritis Rheum 39: 1998-2003.
20. Mikelis C Sfaelou E Koutsioumpa M Kieffer N Papadimitriou E. 2009. Integrin avb3 is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase b/z. FASEB J 23:1459-1469.
21. Pai R Szabo IL Giap AQ Kawanaka H Tarnawski AS. 2001. Nonsteroidal anti-inflammatory drugs inhibit re-epithelialization of wounded gastric monolayers by interfering with actin Src FAK and tensin signaling. Life Sci 69:3055-3071.
22. Papadimitriou E Polykratis A Hatziapostolou M Parthymou A Polytarchou C Mikelis C. 2004. Heparin affin regulatory peptide: A new target for tumour therapy? Curr Cancer Drug Tar 4:471-482.
23. Penney AG,Malcontenti-Wilson C O'Brien PE Andrews FJ. 1995. NSAID-induced delay in gastric ulcer healing is not associated with decreased epithelial cell proliferation in rats. Digest Dis Sci 40:2684-2693.
24. Perez-Pinera P Berenson JR Deuel TF. 2008. Pleiotrophin a multifunctiional angiogenic factor: Mechanisms and pathways in normal and pathobiological angiogenesis. Curr Opin Hematol 15:210-214.
25. Peskar BM Maricic N Gretzera B Schuligoi R Schmassmann A. 2001. Role of cyclooxygenase-2 in gastric mucosal defense. Life Sci 69:2993-3003.
26. Polykratis A Katsoris P Courty J Papadimitriou E. 2005. Characterization of heparin affin regulatory peptide signaling in human endothelial cells. J Biol Chem 280:22454-22461.
27. Polytarchou C Hatziapostolou M Poimenidi E Mikelis C Papadopoulou A Parthymou A Papadimitriou E. 2009. Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase b/z. Int J Cancer 124:1785-1793.
28. Pufe T Groth G Goldring MB Tillmann B Mentlein R. 2007. Effects of pleiotrophin a heparin-binding growth factor on human primary and immortalized chondrocytes. Osteoarthr Cartilage 15:155-162.
29. Quaroni A,Wands J Trelstad RL Isselbacher KJ. 1979. Epithelioid cell cultures from rat small intestine: Characterization by morphologic and immunologic criteria. J Cell Biol 80:248-265.
30. Radi ZA. 2009. Pathophysiology of cyclooxygenase inhibition in animal models. Toxicol Pathol 37:34-46.
31. Rahgozar M Pazokitoroudi H Bakhtiarian A Djahanguiri B. 2001.Diazoxide a KATP opener accelerates restitution of ethanol or indomethacin-induce gastric ulceration in rats independent of polyamines. J Gastroenterol Hepatol 16:290-296.
32. Rao JN Platoshyn O Li L Guo X Golovina VA Yuan JX,Wang JY. 2002. Activation of K channels and increased migration of differentiated intestinal epithelial cells after wounding. Am J Physiol 282:C885-C898.
33. Raveendran NN Silver K Freeman LC Narvaez DF Weng K Ganta S Lillich JD. 2008. Drug-induced alterations to gene and protein expression in intestinal epithelial cell 6 cells suggest a role for calpains in the gastrointestinal toxicity of nonsteroidal anti-inflammatory agents. J Pharmacol Exp Ther 325:389-399.
34. Schmassmann A Tarnawski AS Peskar BM Varga L Flogerzi B Halter F. 1995. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: Interaction with indomethacin. Am J Physiol 268:G276-G285.
35. Silver K Leloup L Freeman LC Wells A Lillich JD. 2010. Non-steroidal anti-inflammatory drugs inhibit calpain activity and membrane localization of calpain 2 protease. Int J Biochem Cell Biol 42:2030-2036.
36. Smith CJ Zhang Y Koboldt CM Muhammad J Zweifel BS Shaffer A Talley JJ Masferrer JL Seibert K Isakson PC. 1998 Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci 95:13313-13318.
37. Somasundaram S Sigthorsson G Simpson RJ Watts J Jacob M Tavares IA Rafi S Roseth A Foster R Price AB Wrigglesworth JM Bjarnason I. 2000. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibitiion of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharm Ther 14:639-650.
38. Suh E Traber PG. 1996. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol 16: 619-625.
39. Suzuki T Suganuma T Shimizu R Aoki M Hanano M. 1997. Relationship between pharmacokinetics and the analgesic effect of indomethacin in the rat. Biol Pharmacol Bull 20:438-442.
40. Tanaka A Araki H Komoike Y Hase S Takeuchi K. 2001. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol Paris 95:21-27.
41. Tavares IA. 2000. The effects of meloxicam indomethacin or NS-398 on eicosanoid synthesis by fresh human gastric mucosa. Aliment Pharm Ther 14:795-799.
42. TomisatoW Tsutsumi S Hoshino T Hwang HJ MioM Tsuchiya T Mizushima T. 2004. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol 67:575-585.
43. Ulbricht U Eckerich C Fillbrandt R Westphal M Lamszus K. 2006. RNA interference targeting protein tyrosine phosphatase z/receptor-type protein tyrosine phosphatase b suppresses glioblastoma growth in vitro and in vivo. J Neurochem 98: 1497-1506.
44. Wallace JL Vong L. 2008. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs. Curr Opin Invest Drugs 9:1151-1156.
45. Whittle BJR. 2003. Gastrointestinal effects of nonsteroidal antiinflammatory drugs. Fund Clin Pharm 17:301-313.
46. Wolfe MM Lichtenstein DR Singh G. 1999. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. New Engl J Med 341:1397-1399.